We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+22.12%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.31B
AUM Growth
+$60.5M
Cap. Flow
-$126M
Cap. Flow %
-9.59%
Top 10 Hldgs %
52.31%
Holding
44
New
8
Increased
6
Reduced
15
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 48.96%
2 Consumer Discretionary 17.87%
3 Technology 16.11%
4 Communication Services 5.21%
5 Financials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
1
American Well
AMWL
$177M
$117M 8.95%
231,637
CZR icon
2
Caesars Entertainment
CZR
$6.05B
$82.5M 6.29%
1,110,206
-244,260
-18% -$15.3M
GDDY icon
3
GoDaddy
GDDY
$10.5B
$78.8M 6.01%
950,160
-16,200
-2% -$1.27M
NTRA icon
4
Natera
NTRA
$37.7B
$70.1M 5.34%
704,050
-612,002
-47% -$51.1M
ALXN
5
DELISTED
Alexion Pharmaceuticals
ALXN
$66M 5.03%
422,254
+43,800
+12% +$5.63M
POST icon
6
Post Holdings
POST
$4.18B
$55.3M 4.22%
836,138
ROST icon
7
Ross Stores
ROST
$80.7B
$55.2M 4.21%
449,783
+111,576
+33% +$11.7M
CHTR icon
8
Charter Communications
CHTR
$17.3B
$54.5M 4.15%
82,317
-3,042
-4% -$1.94M
ALC icon
9
Alcon
ALC
$33.4B
$54.3M 4.14%
822,471
-175,595
-18% -$11M
UBER icon
10
Uber
UBER
$142B
$51.9M 3.96%
1,018,500
+218,500
+27% +$9.79M
MRK icon
11
Merck
MRK
$322B
$48.2M 3.68%
617,755
+129,129
+26% +$9.88M
MS icon
12
Morgan Stanley
MS
$334B
$44.8M 3.42%
653,530
-163,500
-20% -$9.38M
GDS icon
13
GDS Holdings
GDS
$6.46B
$43.1M 3.28%
459,904
ALNY icon
14
Alnylam Pharmaceuticals
ALNY
$27.3B
$40.8M 3.11%
313,632
-45,602
-13% -$6.09M
LKQ icon
15
LKQ Corp
LKQ
$5.69B
$39.7M 3.02%
1,125,180
-151,528
-12% -$5.18M
VRSN icon
16
VeriSign
VRSN
$26.2B
$37.4M 2.85%
172,604
HCA icon
17
HCA Healthcare
HCA
$86.1B
$35.9M 2.74%
218,454
-139,652
-39% -$20.4M
INCY icon
18
Incyte
INCY
$24.3B
$35.2M 2.68%
404,650
+61,700
+18% +$5.34M
ETSY icon
19
Etsy
ETSY
$7.77B
$33M 2.52%
185,703
ATRA icon
20
Atara Biotherapeutics
ATRA
$72.5M
$29.9M 2.28%
60,990
-2,304
-4% -$1.06M
IRWD icon
21
Ironwood Pharmaceuticals
IRWD
$680M
$28.1M 2.14%
2,466,972
-308,495
-11% -$3.38M
FTDR icon
22
Frontdoor
FTDR
$5.1B
$23.9M 1.82%
475,000
+250,000
+111% +$11.4M
SQZ
23
DELISTED
SQZ Biotechnologies Company
SQZ
$23.4M 1.79%
+807,827
New +$20.6M
PVG
24
DELISTED
PRETIUM RESOURCES INC.
PVG
$16.1M 1.23%
1,406,412
TEVA icon
25
Teva Pharmaceuticals
TEVA
$40.6B
$14.5M 1.1%
1,500,000

Similar funds

Bridger Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bridger Management held 44 positions worth $1.31B, up 4.8% from $1.25B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Bridger Management withdrew a net $126M in Q4 2020, closing 5 positions and reducing 15 holdings. Its most notable exit was Centene, an estimated $46.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 55% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Bridger Management opened a new position in SQZ Biotechnologies Company worth $23.4M.

  • Bridger Management's largest Q4 2020 buy was SQZ Biotechnologies Company: 807,827 shares worth $23.4M.
  • Bridger Management added most to Ross Stores in Q4 2020, an estimated $11.7M increase.
  • Bridger Management's biggest Q4 2020 reduction was Natera, cutting an estimated $51.1M.
  • Bridger Management fully exited Centene in Q4 2020, selling an estimated $46.7M.
  • Bridger Management's ten largest holdings make up 52% of its $1.31B portfolio in Q4 2020.
  • Bridger Management opened 8 new positions and closed 5 in Q4 2020.
  • Bridger Management's portfolio value rose 4.8% quarter-over-quarter to $1.31B.

Based on Bridger Management's 13F filing for Q4 2020, filed 16 Feb 2021.